Connect with us
DAPA Banner

Business

HCI Group: Buy One, Get One Free (NYSE:HCI)

Published

on

HCI Group: Buy One, Get One Free (NYSE:HCI)

This article was written by

I analyze securities based on value investing, an owner’s mindset, and a long-term horizon. I don’t write sell articles, as those are considered short theses, and I never recommend shorting.I was initially interested in a career in politics, but after reaching a dead-end in 2019 and seeing the financial drain this posed, I choose a path that would make my money work for me and protect me from more setbacks. This brought me to study value investing, in order to grow wealth with risk management in mind.From 2020 to 2022, I worked in a sales role at a law firm. As the top-grossing salesman, I eventually managed a team and contributed to our sales strategy. I spent much of my free time reading books and annual reports, steadily building my vault of knowledge about public companies. This period has since been useful in helping me assess a company’s prospects by its sales strategy. I particularly get excited when the product seems to sell itself.From 2022 to 2023, I worked as an investment advisory rep with Fidelity, primarily with 401K planning. My personal study before that allowed me to pass my Series exams two weeks ahead of schedule, and I once again found myself excelling at the job. I learned a few useful things from this more formal setting, but my main frustration was that I was still a value investor, and Fidelity’s 401K planning was based on modern portfolio theory. Lacking a way to change positions internally, I chose to walk away after a year.I gave writing for Seeking Alpha a try in November of 2023, and I’ve been here since. As I spent those years saving aggressively and building up my base of capital, I also actively invest now. My articles are how I share the opportunities that I seek for myself, and my readers are effectively walking this road alongside me.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Bentley workers 'shocked and angry' at job cuts

Published

on

Bentley workers 'shocked and angry' at job cuts

A union says the announcement came as a blow to employees with up to 275 positions at risk.

Continue Reading

Business

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

Published

on

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.

Kyle Grillot | Bloomberg | Getty Images

Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.

Advertisement

The FDA approved the pill, Icotyde, to treat moderate to severe plaque psoriasis, an autoimmune condition that causes rough patches of skin. Patients typically start treatment with topical medications.

If those don’t work, they advance to pills or shots. J&J sees Icotyde becoming the first-line systematic treatment for psoriasis, in between topicals and shots.

Drugmakers have been developing more advanced medicines than standard topicals, turning psoriasis into a highly competitive space. Icotyde targets the same IL-23 receptor as best-selling shots like J&J’s Tremfya and AbbVie‘s Skyrizi, giving patients an oral alternative to some of the most advanced — and most expensive — drugs on the market.

“To be able to to be able to have something that is relatively simple, that offers that level of clearance, trusted safety profile, and in a simple pill, we think is going to be revolutionary,” said Jennifer Taubert, chairman of J&J Innovative Medicine.

Advertisement

J&J estimates about 8 million people in the U.S. have plaque psoriasis, and that 75% of people don’t advance from topicals to shots because of reasons like fearing needles. Taubert sees Icotyde appealing to those patients.

“We believe having the type of profile that Icotyde has in a simple, once-daily oral pill, we think it’s going to be an absolute game changer for patients,” Taubert said.

J&J hasn’t announced how much Icotyde will cost beyond saying the company will help people pay for the medicine. Rival shots Tremfya and Skyrizi cost around $100,000 a year.

J&J sees peak annual sales of Icotyde exceeding $5 billion once it’s approved for other autoimmune conditions. It’s testing the drug for psoriatic arthritis, ulcerative colitis and Crohn’s disease.

Advertisement

Shares of J&J slid one-quarter of a percent Wednesday while shares of Skyrizi-maker AbbVie fell more than 4%. Protagonist Therapeutics, a biotech company that developed Icotyde with J&J, was trading about flat.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Brightstar Lottery stock hits 52-week low at 12.6 USD

Published

on


Brightstar Lottery stock hits 52-week low at 12.6 USD

Continue Reading

Business

Stocks Can’t Recover While Oil Prices Surge. Why the Fed’s Unlikely to Help.

Published

on

Stocks Can’t Recover While Oil Prices Surge. Why the Fed’s Unlikely to Help.

Stocks Can’t Recover While Oil Prices Surge. Why the Fed’s Unlikely to Help.

Continue Reading

Business

US holds interest rates as Iran war triggers oil shock

Published

on

US holds interest rates as Iran war triggers oil shock

The US central bank is moving cautiously, despite pressure from the president to cut interest rates.

Continue Reading

Business

Big Tech’s Huge Conglomerate Premium

Published

on

Big Tech’s Huge Conglomerate Premium

Big Tech’s Huge Conglomerate Premium

Continue Reading

Business

Datassential reveals top emerging foodservice chains

Published

on

Datassential reveals top emerging foodservice chains

Top chains specialized in focused concepts and tapped into trending flavors.

Continue Reading

Business

Hewlett Packard Enterprise's AI Story Moved To The Network Layer

Published

on

Hewlett Packard Enterprise's AI Story Moved To The Network Layer

Hewlett Packard Enterprise's AI Story Moved To The Network Layer

Continue Reading

Business

Iran’s military escalation backfiring, former Israeli general consul says

Published

on

Iran's military escalation backfiring, former Israeli general consul says

Iran’s latest military escalation is backfiring on the global stage as new strikes and widening regional fallout expose what a former Israeli consul general in New York called a critical miscalculation by Tehran.

Ambassador Ido Aharoni, who served as consul general of Israel in New York, joined FOX Business’ “Mornings With Maria” on Wednesday to discuss the broader implications of Iran’s recent actions and the shifting dynamics across the Middle East.

Advertisement
Iran flag in rubble and debris

An Iranian flag lies amid rubble and debris in Tehran. (Atta Kenare/AFP via Getty Images)

“Iran made a terrible mistake attacking Cyprus, thus bringing in the European Union,” Aharoni told host Maria Bartiromo.

He said Iran’s decision to expand its targets is drawing in new international pressure and raising concerns far beyond the region.

IRAN WAR UNLIKELY TO TRIGGER GLOBAL SUPPLY CHAIN CRISIS, GOLDMAN SACHS SAYS

“Iran is presenting a threat to the entire world,” Aharoni said.

Advertisement

The former consul general argued the U.S. and Israel’s ongoing military campaign is reshaping deterrence and exposing the regime’s vulnerabilities.

“For the first time since 1979, Iran is being punished for its motivation, for its ideology, not just for their actions… This sends a very powerful message throughout the region,” Aharoni said.

“This is how you restore deterrence… This is exactly what is being done.”

Advertisement

PRINCE REZA PAHLAVI HAS ‘MAJORITY SUPPORT’ AMONG IRANIANS AS PRESSURE BUILDS ON REGIME, CHIEF OF STAFF SAYS

He said Iran’s long-term position is weakening as a result of Operation Epic Fury. 

“They’re not going to be the same regional power that they were before or after this. It will take them decades to rebuild the infrastructure that was destroyed,” Aharoni explained.

Aharoni underscored that Iran’s actions are impacting its own population as instability grows.

“The Iranians are the number one victims of their own regime,” Aharoni said.

CLICK HERE TO GET FOX BUSINESS ON THE GO

Advertisement
Continue Reading

Business

JD Vance vows gas prices will drop as Iran conflict ends

Published

on

JD Vance vows gas prices will drop as Iran conflict ends

The Trump administration is working to lower gas prices as motorists continue to pay more at the pump since the outbreak of the Iran war, Vice President JD Vance said Wednesday, noting that the increase is temporary. 

Vance was at the Engineering Design Services, Inc. manufacturing plant in Auburn Hills, Michigan, where he was asked about rising gas prices.

Advertisement

“Gas prices are up, and we know they’re up,” Vance said. “We know that people are hurting because of it, and we’re doing everything that we can to ensure that they stay lower.”

Vance said prices will eventually start to decline. 

AMERICANS HIT WITH SOARING ELECTRICITY BILLS AS PRICE HIKES OUTPACE INFLATION NATIONWIDE

Vice President JD Vance

 Vice President JD Vance speaks onstage at Engineering Design Services, Inc. on Wednesday in Auburn Hills, Michigan.  (Bill Pugliano/Getty Images / Getty Images)

“The president said this, and I certainly agree with it. This is a temporary blow,” he said. “What happened under the Biden administration is that gas prices were high for four years. Gas prices are higher right now, and frankly, they’re not even as high as they were during certain parts of the Biden administration.”

Advertisement

Prices have steadily risen following U.S. and Israeli attacks against Iran in recent weeks. 

As of Wednesday, the average price for a regular gallon of gas was $3.84, up from $2.92 a month ago, according to AAA.

GAS PRICES SURGE, PINCHING AMERICANS AND HANDING THE GOP A NEW MIDTERM HEADACHE

Gas pump

A diesel fuel pump at a Chevron gas station in Seattle, Washington, US, on Monday, March 9, 2026. (M. Scott Brauer/Bloomberg via Getty Images / Getty Images)

In recent weeks, the administration has worked with its allies to release hundreds of millions of barrels of oil from petroleum reserves in an effort to put downward pressure on prices, Vance said. 

Advertisement

Many U.S. allies are “suffering” much more than many Americans, Vance said. 

“So as much as we’ve got to focus on getting these gas prices down, the reality is, overseas they’re feeling it far worse than we did because we’ve taken the steps to protect our energy economy.”

Once military operations against Iran conclude, prices should decrease to previous levels, said Vance. 

CLICK HERE TO GET FOX BUSINESS ON THE GO

“We promise that when this conflict draws to a close, when this operation draws to close, we’re going to see those energy prices come back down to reality, because that’s what the president promised to do,” he said. “He delivered an energy-dominant agenda. It’s made us much more secure in the face of these things. But yeah, we’ve got a rough road ahead of us for the next few weeks, but it’s temporary.”

The U.S. produces more oil than any other country, according to the Energy Information Administration (EIA). As of 2023, the latest data available, the U.S. produces 1roughly3 millions barrels per day, followed by Russia and Saudi Arabia.

Advertisement
Continue Reading

Trending

Copyright © 2025